• No results found

Towards peptide based therapeutics-applications in celiac disease and infectious diseases Kapoerchan, V.V.

N/A
N/A
Protected

Academic year: 2021

Share "Towards peptide based therapeutics-applications in celiac disease and infectious diseases Kapoerchan, V.V."

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

disease and infectious diseases

Kapoerchan, V.V.

Citation

Kapoerchan, V. V. (2009, December 22). Towards peptide based

therapeutics-applications in celiac disease and infectious diseases. Retrieved from https://hdl.handle.net/1887/14542

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/14542

Note: To cite this publication please use the final published version (if

applicable).

(2)

Appendix

Figure 1Schematic representation of the HLA-DQ2 protein. The α en β chains are indicated in red and blue, with a bound gluten peptide indicated in yellow. Left: side view. Right: the binding pocket made up by two helices of each subunit and a β-sheet on the bottom. Pictures taken from the crystal structure provided in ref. 1.

Figure 2 Schematic representation of the pathogenesis of CD.

a) Digestion of gluten to small peptide fragments rich in proline and glutamine. b) Internalization of peptide fragments by the APC and weak binding of some peptides to HLA-DQ2 (APC = antigen presenting cell). c) Recognition by gluten-positive CD4+ T cell (TCR = T cell receptor). d) Conversion of selected glutamine residues to glutamates in the peptides by tTG. e) Enhanced binding of deamidated peptides and enhanced T cell recognition.

e c gluten TCR

peptides CD4

+

T cel a

gluten

HLA-DQ2

Immune response with tissue damage and release of tTG as a result

b

Amplified immune response

d tTG deamidated gluten peptides

(3)

Figure 3The crystal structure of HLA-DQ2 with peptide QLQPFPQPELPY (epitope shown in bold), shown in red. The prolines at positions p3 and p5 are both highlighted in yellow and clearly do not show any interaction with the HLA-DQ2 binding pocket. This picture was taken from the crystal structure provided in ref. 1.

Figure 4 a) Close view of the HLA-DQ2 p1 binding pocket occupied by a proline residue. The bound α- 9 peptide is indicated in yellow, the proline at p1 in red, the negatively charged Glu at the bottom of the pocket in purple and the positively charged His residue halfway the pocket in blue. Water molecules and some amino acid residues are omitted for clarity. b) Schematic representation of the p1 pocket of the HLA-DQ2 binding pocket, showing the hydrogen bond network formed by the three water molecules.

a b

O O HN NH

HOH HOH

H OH

Figure 5 Top view (left) and side view (right)of the GS molecule. Side chains are partially omitted for clarity.2 In top view, hydrogen bonds (stabilizing the secondary structure) are indicated by thin green lines. The side view clearly shows the separation of hydrophobic and charged residues.

Side view Top view

(4)

Figure 6The crystal structure of peptide 9. a) Top view of 9, with side chains partly omitted for clarity.

Dotted lines indicate hydrogen bonds stabilizing the secondary structure. b) Side view of 9. Arrows indicate the presence of additional methyl groups as compared to GS.

a b

Figure 7 a) X-ray analysis of peptide 7. Side (left) and top view (right) of the peptide monomer. In top view, side chains are omitted for clarity. Intramolecular hydrogen bonds are indicated with dotted lines.

The arrow indicates the ‘amide flip’. b) Side and top view of the monomer of 8. c) Side (left) and top (right) view of the GS molecule.2 In top view, hydrogen bonds (stabilizing the secondary structure) are depicted by thin green lines.

amide flip a

7

less amide flip b

8

c

(5)

Figure 8Structural characteristics of 8 according to X-ray analysis. a) Side and top view of the channel with each monomer highlighted in a different color. b) Side view with the MAA residues highlighted in red, and the ornithine side chain in yellow. c) Hydrogen bonding of the MAA residue to the ornithine of another monomer, indicated by a cyan dotted line. The ornithine side chain is highlighted in yellow, the MAA in red. Side chains are partially omitted for clarity.

a

c

b

(6)

Figure 9 Comparison of β-turn structures. All six-membered morpholine rings assume a chair conformation. Hydrogen bonds are depicted as dashed lines. Of peptide 9, the conformation of the MAA-Leu9 amide bond is uncertain and therefore depicted as CONH. The crystal structures, if available, of the turn regions are depicted next to the corresponding structural formulas, hydrogens and side chains are omitted for clarity. Hydrogen bonds are depicted as dotted lines.

N O

6 7

8 9

GS N

HN O O

HN O

NH O

HN HN

O

NH O

N O

HN HN

O

O O

N O

HN HN

O

NH O

O

N O

HN

NH O

O O

NH H

H

H H

H H

H H

CONH

7

8

(7)

References

1. Kim, C. Y.; Quarsten, H.; Bergseng, E.; Khosla, C.; Sollid, L. M.; Proc. Natl. Acad.

Sci. USA 2004, 101, 4175-4179.

2. Llamas-Saiz, A. L.; Grotenbreg, G. M.; Overhand, M.; Van Raaij, M. J. Acta Cryst.

2007, D63, 401-407.

Referenties

GERELATEERDE DOCUMENTEN

Towards peptide based therapeutics-applications in celiac disease and infectious diseases..

43,44 As HLA-DQ2 and HLA-DQ8 are known to preferentially bind peptides that harbor negatively charged amino acids, some of these glutamate containing peptides bind to HLA-DQ2

‘superbinders’ have at least a 60-fold higher binding affinity than -9 it can be concluded that the modified ‘superbinders’ 19-27 are still better HLA-DQ2 binders than the

In this thesis I will give an overview of the most recent insights in NRPS structure and dynamics per domain, to find out if it is possible to find a structure of an entire

In this thesis, we aimed to develop novel peptide ligands by a combined phage display and bioorganic synthesis strategy and to investigate the targeted potential of developed

In hoofdstuk 3 hebben we met succes een nieuwe SR-AI bindend peptide geïdentificeerd door middel van een geavanceerde moleculair biologische techniek, peptide faagdisplay, en

Therapeutic Potential of VIVIT, a selective peptide inhibitor of Nuclear Factor of Activated T-cells, in cardiovascular disorders.. Cardiovascular

Application of phage display derived peptide ligands for scavenger receptor-AI as homing device for contrast agents will not only improve the sensitivity of atherosclerotic plaque